Dr. Priyom Bose

Dr. Priyom Bose

Feature Writer

B.Sc. Botany, M.Sc. Plant Biology and Biotechnology, Ph.D. Plant Biology and Biotechnology

Priyom holds a Ph.D. in Plant Biology and Biotechnology from the University of Madras, India. She is an active researcher and an experienced science writer. Priyom has also co-authored several original research articles that have been published in reputed peer-reviewed journals. She is also an avid reader and an amateur photographer.

Articles from Priyom

Sixteen countries reported monkeypox virus infection in humans between April and June 2022

Sixteen countries reported monkeypox virus infection in humans between April and June 2022

27 Jul 2022
Population-based cohort study investigates the effect of SARS-CoV-2 infection on pregnancy outcomes

Population-based cohort study investigates the effect of SARS-CoV-2 infection on pregnancy outcomes

27 Jul 2022
Study confirms efficacy of molnupiravir against COVID in a real-life cohort

Study confirms efficacy of molnupiravir against COVID in a real-life cohort

26 Jul 2022
Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

26 Jul 2022
A VSV-based COVID vaccine effective against SARS-CoV-2 variants

A VSV-based COVID vaccine effective against SARS-CoV-2 variants

25 Jul 2022
Bivalent mRNA vaccine induces powerful antibody response to SARS-CoV-2 Omicron subvariants

Bivalent mRNA vaccine induces powerful antibody response to SARS-CoV-2 Omicron subvariants

25 Jul 2022
High-level resistance of SARS-CoV-2 BA.4 against neutralizing antibodies

High-level resistance of SARS-CoV-2 BA.4 against neutralizing antibodies

20 Jul 2022
COVID vaccines induce memory B and T cells in primary antibody deficient patients

COVID vaccines induce memory B and T cells in primary antibody deficient patients

20 Jul 2022
How the Omicron variant shifted the biology of SARS-CoV-2

How the Omicron variant shifted the biology of SARS-CoV-2

20 Jul 2022
Chewing gum containing plant-based antiviral proteins neutralizes SARS-CoV-2 and influenza viruses

Chewing gum containing plant-based antiviral proteins neutralizes SARS-CoV-2 and influenza viruses

20 Jul 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback